America COVID-19
Corona Updates
COVID-19
US Corona
Scientists are reaching a new understanding about Alzheimer's disease
Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, back after a week away to ski and feeling refreshed. Today in healthcare news:
- Scientists have a new way of thinking about Alzheimer's disease;
- Pfizer's and Moderna's shots are 90% effective out in the real world;
- See the investor presentation Crossover Health gave at a January investor conference.
If you're new to this newsletter, sign up here. Comments, tips, tricks for successfully scheduling vaccine appointments in the state of Colorado? Email me at lramsey@insider.com or tweet @lydiaramsey125. Now, let's get to it...
Scientists are coming around to a surprising new understanding of Alzheimer's disease, and it could supercharge drug development for the $1.1 trillion problem
- Caring for patients with Alzheimer's disease is expected to cost $1.1 trillion in the U.S. by 2050.
- Hopes for a universal treatment are dwindling after 146 experimental drugs failed in human trials.
- New genetic insights are upending the way scientists approach Alzheimer's.
lechatnoir/Getty Images
lechatnoir/Getty Images
CDC: Real-world data shows Pfizer's and Moderna's COVID-19 vaccines are 90% effective at preventing infection
- A study from the CDC provides early evidence that vaccinated people don't often transmit COVID-19.
- It included nearly 4,000 healthcare and frontline workers who got mRNA shots from Pfizer or Moderna.
- The shots were 80% effective two weeks after the first dose and 90% effective two weeks after both.
Crossover Health
An investor presentation lays out how a key healthcare partner for Amazon is thinking about the future of its business
- Crossover Health just raised $168 million in a round led by Deerfield Management Company.
- The buzzy startup works with companies like Amazon to set up clinics and telehealth for employees.
- "Virtual-first" primary care like Crossover's is emerging as a popular tool to cut healthcare costs.
More stories we're reading today:
- CDC director fights back tears as she warns of soaring COVID-19 cases: 'Right now I'm scared (Insider)
- What happened when Reno, Nevada spent $1.3 million on teletherapy access from Talkspace (Stat News)
- New Yorkers ages 30 and over can get the COVID-19 vaccine Tuesday, and people 16 and over can get it next week (Insider)
- One of America's richest Black people is hiding in plain sight. His $2.2 billion pharma company could improve life for millions of people with Alzheimer's. (Insider)
- What it'll take to implement "vaccine passports" (Washington Post)
- Lydia
Read the original article on Business Insider
from Business Insider https://ift.tt/3ua2ZrY
No comments